<?xml version='1.0' encoding='utf-8'?>
<document id="26365335"><sentence text="Investigation of a potential pharmacokinetic interaction between perindopril arginine and amlodipine when administered as a single perindopril/amlodipine fixed-dose combination tablet in healthy Chinese male volunteers."><entity charOffset="65-85" id="DDI-PubMed.26365335.s1.e0" text="perindopril arginine" /><entity charOffset="90-100" id="DDI-PubMed.26365335.s1.e1" text="amlodipine" /><entity charOffset="131-142" id="DDI-PubMed.26365335.s1.e2" text="perindopril" /><entity charOffset="143-153" id="DDI-PubMed.26365335.s1.e3" text="amlodipine" /><pair ddi="false" e1="DDI-PubMed.26365335.s1.e0" e2="DDI-PubMed.26365335.s1.e0" /><pair ddi="false" e1="DDI-PubMed.26365335.s1.e0" e2="DDI-PubMed.26365335.s1.e1" /><pair ddi="false" e1="DDI-PubMed.26365335.s1.e0" e2="DDI-PubMed.26365335.s1.e2" /><pair ddi="false" e1="DDI-PubMed.26365335.s1.e0" e2="DDI-PubMed.26365335.s1.e3" /><pair ddi="false" e1="DDI-PubMed.26365335.s1.e1" e2="DDI-PubMed.26365335.s1.e1" /><pair ddi="false" e1="DDI-PubMed.26365335.s1.e1" e2="DDI-PubMed.26365335.s1.e2" /><pair ddi="false" e1="DDI-PubMed.26365335.s1.e1" e2="DDI-PubMed.26365335.s1.e3" /><pair ddi="false" e1="DDI-PubMed.26365335.s1.e2" e2="DDI-PubMed.26365335.s1.e2" /><pair ddi="false" e1="DDI-PubMed.26365335.s1.e2" e2="DDI-PubMed.26365335.s1.e3" /></sentence><sentence text="To determine whether a potential pharmacokinetic interaction exists between perindopril arginine 5 mg and amlodipine 5 mg, after administration as a fixed-combination of perindopril 5 mg/amlodipine 5 mg (S05985)"><entity charOffset="76-96" id="DDI-PubMed.26365335.s2.e0" text="perindopril arginine" /><entity charOffset="106-116" id="DDI-PubMed.26365335.s2.e1" text="amlodipine" /><entity charOffset="170-181" id="DDI-PubMed.26365335.s2.e2" text="perindopril" /><entity charOffset="187-197" id="DDI-PubMed.26365335.s2.e3" text="amlodipine" /><pair ddi="false" e1="DDI-PubMed.26365335.s2.e0" e2="DDI-PubMed.26365335.s2.e0" /><pair ddi="false" e1="DDI-PubMed.26365335.s2.e0" e2="DDI-PubMed.26365335.s2.e1" /><pair ddi="false" e1="DDI-PubMed.26365335.s2.e0" e2="DDI-PubMed.26365335.s2.e2" /><pair ddi="false" e1="DDI-PubMed.26365335.s2.e0" e2="DDI-PubMed.26365335.s2.e3" /><pair ddi="false" e1="DDI-PubMed.26365335.s2.e1" e2="DDI-PubMed.26365335.s2.e1" /><pair ddi="false" e1="DDI-PubMed.26365335.s2.e1" e2="DDI-PubMed.26365335.s2.e2" /><pair ddi="false" e1="DDI-PubMed.26365335.s2.e1" e2="DDI-PubMed.26365335.s2.e3" /><pair ddi="false" e1="DDI-PubMed.26365335.s2.e2" e2="DDI-PubMed.26365335.s2.e2" /><pair ddi="false" e1="DDI-PubMed.26365335.s2.e2" e2="DDI-PubMed.26365335.s2.e3" /></sentence><sentence text="" /><sentence text="A total of 30 subjects was enrolled into this single center, open-label, randomized, 3-period cross-over study and was randomized to receive 1 tablet of S05985, 1 tablet of perindopril tert-butylamine 4 mg, or 1 tablet of amlodipine 5 mg"><entity charOffset="173-200" id="DDI-PubMed.26365335.s4.e0" text="perindopril tert-butylamine" /><entity charOffset="222-232" id="DDI-PubMed.26365335.s4.e1" text="amlodipine" /><pair ddi="false" e1="DDI-PubMed.26365335.s4.e0" e2="DDI-PubMed.26365335.s4.e0" /><pair ddi="false" e1="DDI-PubMed.26365335.s4.e0" e2="DDI-PubMed.26365335.s4.e1" /></sentence><sentence text=" The doses of both perindopril salts correspond to 3"><entity charOffset="19-30" id="DDI-PubMed.26365335.s5.e0" text="perindopril" /></sentence><sentence text="34 mg of perindopril expressed as free acid"><entity charOffset="9-20" id="DDI-PubMed.26365335.s6.e0" text="perindopril" /></sentence><sentence text=" Serial blood samples were collected in each treatment period for determination of plasma amlodipine, perindopril, and perindoprilat concentrations and for calculation of the respective pharmacokinetic parameters (AUC(0-∞), AUC(0-t), C(max), and t(max))"><entity charOffset="90-100" id="DDI-PubMed.26365335.s7.e0" text="amlodipine" /><entity charOffset="102-113" id="DDI-PubMed.26365335.s7.e1" text="perindopril" /><entity charOffset="119-132" id="DDI-PubMed.26365335.s7.e2" text="perindoprilat" /><pair ddi="false" e1="DDI-PubMed.26365335.s7.e0" e2="DDI-PubMed.26365335.s7.e0" /><pair ddi="false" e1="DDI-PubMed.26365335.s7.e0" e2="DDI-PubMed.26365335.s7.e1" /><pair ddi="false" e1="DDI-PubMed.26365335.s7.e0" e2="DDI-PubMed.26365335.s7.e2" /><pair ddi="false" e1="DDI-PubMed.26365335.s7.e1" e2="DDI-PubMed.26365335.s7.e1" /><pair ddi="false" e1="DDI-PubMed.26365335.s7.e1" e2="DDI-PubMed.26365335.s7.e2" /></sentence><sentence text=" Statistical analyses of the pharmacokinetic parameters included ANOVA and calculations of 90% confidence intervals for the ratio of the geometric means for Cmax, AUC(0-t), and AUC(0-∞)" /><sentence text=" Safety was also assessed" /><sentence text="" /><sentence text="A total of 29 subjects completed the study per protocol" /><sentence text=" There was no serious adverse event" /><sentence text=" All 90% confidence intervals for C(max), AUC(0-t), and AUC(0-∞) for perindopril, perindoprilat, and amlodipine were within the limits (80"><entity charOffset="56-64" id="DDI-PubMed.26365335.s13.e0" text="AUC(0-∞)" /><entity charOffset="69-80" id="DDI-PubMed.26365335.s13.e1" text="perindopril" /><entity charOffset="82-95" id="DDI-PubMed.26365335.s13.e2" text="perindoprilat" /><entity charOffset="101-111" id="DDI-PubMed.26365335.s13.e3" text="amlodipine" /><pair ddi="false" e1="DDI-PubMed.26365335.s13.e0" e2="DDI-PubMed.26365335.s13.e0" /><pair ddi="false" e1="DDI-PubMed.26365335.s13.e0" e2="DDI-PubMed.26365335.s13.e1" /><pair ddi="false" e1="DDI-PubMed.26365335.s13.e0" e2="DDI-PubMed.26365335.s13.e2" /><pair ddi="false" e1="DDI-PubMed.26365335.s13.e0" e2="DDI-PubMed.26365335.s13.e3" /><pair ddi="false" e1="DDI-PubMed.26365335.s13.e1" e2="DDI-PubMed.26365335.s13.e1" /><pair ddi="false" e1="DDI-PubMed.26365335.s13.e1" e2="DDI-PubMed.26365335.s13.e2" /><pair ddi="false" e1="DDI-PubMed.26365335.s13.e1" e2="DDI-PubMed.26365335.s13.e3" /><pair ddi="false" e1="DDI-PubMed.26365335.s13.e2" e2="DDI-PubMed.26365335.s13.e2" /><pair ddi="false" e1="DDI-PubMed.26365335.s13.e2" e2="DDI-PubMed.26365335.s13.e3" /></sentence><sentence text="00 - 125%), indicating that both treatments were bioequivalent" /><sentence text="" /><sentence text="These results indicate that no drug-drug interaction exists after single-dose oral administration of S05985 (perindopril 5 mg and amlodipine 5 mg) when compared to single-dose administration of each component alone, i"><entity charOffset="109-120" id="DDI-PubMed.26365335.s16.e0" text="perindopril" /><entity charOffset="130-140" id="DDI-PubMed.26365335.s16.e1" text="amlodipine" /><pair ddi="false" e1="DDI-PubMed.26365335.s16.e0" e2="DDI-PubMed.26365335.s16.e0" /><pair ddi="false" e1="DDI-PubMed.26365335.s16.e0" e2="DDI-PubMed.26365335.s16.e1" /></sentence><sentence text="e" /><sentence text=", perindopril tert-butylamine 4 mg and amlodipine 5 mg, given separately"><entity charOffset="2-29" id="DDI-PubMed.26365335.s18.e0" text="perindopril tert-butylamine" /><entity charOffset="39-49" id="DDI-PubMed.26365335.s18.e1" text="amlodipine" /><pair ddi="false" e1="DDI-PubMed.26365335.s18.e0" e2="DDI-PubMed.26365335.s18.e0" /><pair ddi="false" e1="DDI-PubMed.26365335.s18.e0" e2="DDI-PubMed.26365335.s18.e1" /></sentence><sentence text="" /></document>